Resultados de la búsqueda

Raposeiras-Roubin S, Amat-Santos IJ, Rossello X, González Ferreiro R, González Bermúdez I, Lopez Otero D, Nombela-Franco L, Gheorghe L, Diez JL, Baladrón Zorita C, Baz JA, Muñoz García AJ, Vilalta V, Ojeda-Pineda S, de la Torre Hernández JM, Cordoba Soriano JG, Regueiro A, Bordes Siscar P, Salgado Fernández J, Garcia Del Blanco B, Martín-Reyes R, Romaguera R, Moris C, García Blas S, Franco-Peláez JA, Cruz-González I, Arzamendi D, Romero Rodríguez N, Díez-Del Hoyo F, Camacho Freire S, Bosa Ojeda F, Astorga Burgo JC, Molina Navarro E, Caballero Borrego J, Ruiz Quevedo V, Sánchez-Recalde Á, Peral Disdier V, Alegría-Barrero E, Torres-Llergo J, Feltes G, Fernández Díaz JA, Cuellas C, Jiménez Britez G, Sánchez-Rubio Lezcano J, Barreiro-Pardal C, Núñez-Gil I, Abu-Assi E, Iñiguez-Romo A, Fuster V, Ibáñez B; DapaTAVI Investigators. Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation. N Engl J Med (2025) 392:1396-1405

Rossello X, Kristensen AMD. Clopidogrel use in chronic coronary syndrome: a fragile lifelong choice. Lancet (2025) 405:1208-1209

Byrne RA, Valgimigli M, Bhatt DL, Coughlan JJ, Gibson CM, Rossello X, Gorog DA, Ibanez B, James S, Landi A, Steg PG, Stone GW, Andreotti F. Great debate: default duration of dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndrome should be 12 months. Eur Heart J (2025) 46:1965-1978

Manninger M, Rubini M, Camm CF. A new European Society of Cardiology Mentoring Programme for young cardiovascular professionals. Eur Heart J (2025) 46:2364-2366

Fuster V, Ibanez B. The Long-Awaited American ACS Guideline: Closer to a Universal Document. J Am Coll Cardiol (2025) 85:2061-2063.

Devesa A, Delgado V, Valkovic L, Lima JAC, Nagel E, Ibanez B, Raman B. Multiorgan Imaging for Interorgan Crosstalk in Cardiometabolic Diseases. Circ Res (2025) 136:1454-1475

Ghigo A, Ameri P, Asnani A, Bertero E, de Boer RA, Farmakis D, González A, Heymans S, Ibáñez B, López-Fernández T, Lyon AR, Pollesello P, Rakisheva A, Stellos K, Streckfuss-Bömeke K, Tocchetti CG, Thum T, van der Meer P, Van Rooij E, Ponikowski P, Metra M, Rosano G, Van Linthout S. Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart. Eur J Heart Fail (2025) 27:1028-1046
Link to the full text in Repisalud

Medina-Hernández D, Galán-Arriola C, Sánchez-González J, Ochala J, Ibáñez B. Anthracycline cardiotoxicity is associated with aberrant cardiac myosin energetics. Rev Esp Cardiol (2025) S1885-5857:00054-4

Rubini Giménez M, Koechlin L, López-Ayala P, Spagnuolo C, Boeddinghaus J, Wildi K, Nestelberger T, Tkachenko H, Basic D, Kaplan E, Formambuh J, Bima P, Glaeser J, Crisanti L, Miró Ó, Martín-Sánchez FJ, Christ M, Keller DI, Gualandro DM, Kawecki D, Rentsch K, Buser A, Strebel I, Mahfoud F, Mueller C; APACE Investigators; Hure G, Rumora K, Muench-Gerber T, Glarner N, Puelacher C, Twerenbold R, Wussler D, du Fay de Lavallaz J, Zimmermann T, Reinhardt J, Morawiec B, Munzk P, Geigy N, Shrestha S, Martinez-Nadal G, Fuenzalida C, Calderón S, Rodriguez Adrada E, Ganovská E, Parenica J, von Eckardstein A. Clinical implications of sex-specific upper reference limits for high-sensitivity cardiac troponin I in myocardial infarction diagnosis. Rev Esp Cardiol (2025) S1885-5857:00147-1

Sanz-Sánchez J, Santos Martínez S, Rumiz González E, Oteo Domínguez JF, Tejada Ponce D, Gómez Menchero A, Sánchez Elvira G, Fuertes Ferre G, Rivero Crespo F, Lukic Otanovic A, Díaz Fernández J, Galindo Fernández E, Urbano Carrillo C, Salvatella Giralt N, Torres Sánchez M, García Touchard A, Ibáñez Cabeza B, Stefanini G, Alfonso Manterola F, García García H, Amat-Santos IJ. Reduced stent strategy versus conventional percutaneous coronary revascularization in patients presenting with STEMI: the COPERNICAN trial. Rev Esp Cardiol (2025) S1885-5857:00150-1